Our Team at CPHI Milan 2024
Dr. Abhinav Gorukanti
CEO
Bhaskar Viswanathan
VP, Business Development
Charan Kalakuntla
Chief of Staff – Operations
Akarshan Gupta
Chief of Staff – Commercial
Rahul TS
AGM, Business Development
About Anthea Pharma
Anthea Pharma, established in 2019 is a R&D focused Injectables firm, backed by the prestigious Yashoda Group. Based out of Hyderabad, India, Anthea Pharma has a world class R&D facility, and an injectable manufacturing facility, currently capable of manufacturing PFS/ Cartridges, Glass & Plastic Vials, Ampoules, Emulsions, Lyophilized Powders & Aqueous Solutions. Anthea Pharma envisions to manufacture for the world and be a global firm focused on injectables needs with a commitment to QUALITY, SPEED, & RELIABILITY.
About CPHI Milan 2024
With a focus on fostering innovation and collaboration, CPHI Milan brings together key players across the pharmaceutical and biotech industries & offers attendees a unique opportunity to explore cutting-edge technologies, products, and services that are shaping the future of pharmaceuticals.
Key Highlights of CPHI Milan 2024:
Global Participation: The event is expected to attract over 62,000 participants and 2,600 exhibitors from more than 166 countries, showcasing its vast global impact and reach.
Showcasing Innovation: The exhibition floor will feature hundreds of global exhibitors presenting the latest advancements & is an ideal opportunity to connect with suppliers from around the world.
Insights from Experts: A series of conferences led by industry pioneers will delve into critical topics such as biopharmaceutical advancements, regulatory updates, and sustainable manufacturing.
Networking Opportunities: CPHI Milan emphasizes networking, offering various formats such as receptions, one-on-one meetings, and matchmaking services
Celebrating Excellence: The prestigious CPHI Pharma Awards will recognize achievements in categories like innovation, sustainability, and leadership.